FDA Approves Multiple Sclerosis Stem Cell Trial – MS – Living …

A recent news report released by the FDA announced the approval of a groundbreaking new study. The basis of the study utilizes advancements in stem cell use to treat multiple sclerosis (MS.) This trial is being performed by Tisch MS Center of New York research teams. Phase one of the trial follows ten years of research.

New Hope for a Cure

If this FDA approved trial is successful in its goals, it portends the beginning of further investigation into new FDA drug approvals. The goals of the study intend to provide clear conclusions of several factors:

The study was performed with the assistance of twenty MS patients who had previously been enrolled in R&D trials and studies. This particular study gives new hope to hundreds of thousands of Americans afflicted with multiple sclerosis. The CDC reports that at least two hundred people will be diagnosed with multiple sclerosis every week.

Use of Stem Cells Is Critical

From early studies performed on patients with other autoimmune diseases, stem cell research has become an acceptable and feasible method of treating certain diseases believed to be incurable.

In some cases, multiple sclerosis patients can experience chronic symptoms. The most serious are advancing paralysis and loss of vision. Continued use of stem cells and research is based on beliefs that regeneration of cells help rebuild or repair damage from diseases like MS. Continued use of stem cells is critical to the future of finding cures for many debilitating diseases that attack the nervous system. Stem cell use for MS patients may reduce episodes of inflammation in nerves that may become worse as the disease progresses.

The Basis of the MS Stem Cell Treatment Study

Researchers at Tisch MS Research Center are working towards determining the safety of injections of stem cells. The procedures in this study will be to use bone marrow taken from MS patients to create a regenerative prognosis. In these patients, stem cells will be by injection into the fluids surrounding their spinal cords. Injections of regenerative stem cells will be done over a period of six months with a follow-up of injections for twenty-seven months. MSC-NPs - The Key to a Future Cure for MS

With these FDA approved trials; the strategy used by researchers is to use mesenchymal stem cell-derived neural progenitor cells, known as MSC-NPS. Extracting these cells from bone marrow of MS patients in a study with seven participants proved to repair areas diseased by MS. The earliest studies performed on lab mice showed positive repair results.

Visit link:
FDA Approves Multiple Sclerosis Stem Cell Trial - MS - Living ...